Results of the Ordinary Shareholders’ Meeting Regulated InformationGhent, Belgium, April 22, 2025 (GLOBE NEWSWIRE) -- Biotalys (Euronext - BTLS...
Biotalys to Appoint Toni Bucci to its Board of Directors Seasoned Agriculture and Biotech Executive With a Passion to Feed the World...
Invitation to the ordinary general shareholders meeting Ghent, BELGIUM, March 21, 2025 (GLOBE NEWSWIRE) -- Press release – regulated information...
Biotalys Reports Full-Year 2024 Financial Results and Business Highlights Ghent, BELGIUM, March 19, 2025 (GLOBE NEWSWIRE) -- Press release –...
Biotalys Achieves Strong Results in Field Trials with Second Biofungicide BioFun-6 Candidate Shows Excellent Efficacy with Increased Potency...
Information on the total number of voting rights and shares Regulated InformationGhent, BELGIUM, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Biotalys NV...
Biotalys Provides Regulatory Review Update on EVOCA Dutch Regulatory Authority CTGB Recommends European Approval; U.S. Review OngoingGhent...
Publication of transparency notifications Article 14(1) of the Law of 2 May 2007 on the disclosure of large shareholders in issuers whose shares...
Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer Company Expands Senior Leadership Team with Experienced Agriculture...
Biotalys announces Closing of Private Placement Information on the total number of voting rights and sharesGhent, BELGIUM, Oct. 16, 2024 (GLOBE...
Biotalys Obtains Subscription Commitments for EUR 15 Million through a Private Placement of New Shares with New and Current Investors Additional...
Biotalys Expands R&D Pipeline with New Biofungicide Program BioFun-8 Will Focus on Combatting Alternaria, a Top Leaf Spot Fungus, in Fruits...
Biotalys Granted Patents for EVOCA in Both Europe and the United States Company Builds Global Intellectual Property Safeguards for Its Crop...
Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands Ghent, Belgium, Sept. 02, 2024 (GLOBE NEWSWIRE...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads